Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Rejuvenation Research is an international, interdisciplinary, peer-reviewed academic journal that covers all aspects of biology and biomedicine relevant to the combating, and ultimately the reversal, of age-related physiological and cognitive decline, in nonhuman species and eventually in humans.
Only manuscripts that conform with guidelines contained herein will be considered for publication. All manuscripts are subject to peer review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication and have not already been published. Submission of an article for publication implies the transfer of the copyright from the author to the Publisher upon acceptance. Accepted papers become the permanent property of Rejuvenation Research and may not be reproduced by any means, in whole or in part, without the written consent of the Publisher.
Page charges for this journal are set at $60.00 USD per typeset page. Nonpayment of page charges may result in a delay in publication. Costs for printing images in color are a separate fee and are not included in the page charge total.
Liebert Instant Online (LION)
To enable the release of new scientific findings as quickly as possible, the Journal has a policy of pre-publishing all manuscripts in their unedited format upon acceptance. The papers will have undergone full peer review but will not yet have been copyedited, typeset, or proofread/corrected by the authors. All accepted papers appear online within 72 hours of acceptance as a part of Liebert Instant Online (LION).
Following its appearance on LION, the paper will progress through the normal production process, including author correction of galley proofs and online publication of the final edited and typeset manuscript ahead of print.
It is essential to note that, as part of the LION program, the data that is published instantly online after acceptance – and in Medline – is pulled directly from the information that was populated into the fields in Manuscript Central upon submission not as listed in the manuscript Word document. Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline/PubMed, until the next revision of the article is published. It is therefore critically important to submit the correct names and email addresses of all authors under the "my authors" section when uploading your manuscript. This author list is what will be used for the Journal’s LION program and its initial listing on PubMed.
No errors appearing on our website, or in Medline, can be corrected until the subsequent revision is published.
The next revision will take place after the corresponding author reviews the page proofs, makes any necessary corrections, and returns the changes to the Publisher. Once all alterations are made, the revised version will be published on our website, and the newly corrected information will be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.
The typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.
Original reports of basic research on aging and ways to combat it.
Original clinical investigations in areas relevant to combating aging.
Original essays which explore theoretical aspects of aging with a clear view toward eventual biomedical implications.
Original discussions of the sociopolitical, economic or ethical implications of extending the healthy and/or total human lifespan.
Paired and opposing reviews of provocative issues in aging. Each author will be invited to write a short response to the opposing review. Reviews and responses will appear in the same issue.
Reviews of a topical area of research relevant to combating aging, discussing the work of multiple research groups.
Accounts of a representative sample of talks or poster presentations at a recent conference or symposium related to combating aging.
Letters regarding articles published recently (in the two most recent issues) in Rejuvenation Research. Authors of such articles will be invited to respond to such letters in the same issue in which the letter is published.
Manuscripts must be submitted online using the following url:
Text must be submitted as a Microsoft Word document and figures as TIFF files at 600 dpi. Submit the text and figure legends as one file but do not include figures OR tables in the main file. Each figure and table should be submitted as a separate file.
Note: All studies involving human or animal subjects should have approval or stated exemption from the author’s institutional review board or animal subject review committee. In research involving human subjects, informed consent must have been obtained in writing as well. Briefly describe the nature of such approval, exemption, or consent in the cover letter. Briefly specify the responsibility of each listed author or consultant in the research, preparation or writing.
Double space only (not 1.5 spacing) and format for printing on 8.5 X 11-inch white paper with margins of at least one inch on all sides. Font size should be no smaller than 12 pt. Number each page, beginning with the title page. The parts of the manuscript should appear in the following order: title page, abstract, main text, acknowledgements, references, tables, figure legends.
The maximum length for Literature Review papers is 6000 words (not including abstract, legends, and references); there should be no more than 150 references and six figures or tables. The maximum length for Correspondence is 1000 words; no more than 10 references and one figure or table. For all other categories the maximum length is 4000 words (not including abstract, legends and references), with no more than 70 references and seven figures or tables.
Include the full title, authors’ names, authors’ full affiliation, information, the phrase “word count” followed by the number of words in the main text (excluding abstract, figures, legend, and references), the phrase “address for correspondence and reprints” followed by the full name, complete mailing address, telephone and fax numbers, and e-mail address of the communicating author, a list of between three and six keywords, and an abbreviated title of at most 45 characters including spaces.
Please be sure to include all authors’ affiliations on the title page. An e-mail, telephone and fax numbers, and mailing address are required on the title page for the corresponding author only.
The abstract should be no more than 250 words. Do not include any abbreviations or references in the abstract.
Tables and Figures
The information portrayed in figures must be self-explanatory, containing sufficient information (together with the legend) that it can be understood clearly without reference to the text. Information should not be given in a table if it can be given in the text in one or two sentences. Illustrations can be printed in color upon subsidy from the author and are encouraged; contact the Publisher for details.
- Each table should be submitted individually and prepared as (a) Word document(s).
- Figures should be submitted as individual .EPS or .TIFF files, not as a Word document and not included in the manuscript text file.
- Table titles should appear above the table on the same page as the table.
- Figure legends should be prepared in one Word document and uploaded as a separate file -- do not include legends at the end of the manuscript.
Please follow these guidelines for submitting figures:
• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at 600 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not file these guidelines may have their submission returned to them without being reviewed.
You will be given directions on how to correct any files which do not pass.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files:
Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
• All files should be scanned at 100% size
• 300 dpi
• Final color mode: cmyk
• save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go to
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
Double space all references. Number each reference consecutively in the manuscript in order of citation. Number references consecutively (not alphabetically) in the reference section. Abbreviations of journal titles should follow MEDLINE. List the names of all authors—do not use et al. Accuracy of citation is the responsibility of the authors; remember that inaccurate references are highly frustrating to the reader, the cited author, and indexing services.
Examples of correct citation include:
Finch CE, Tanzi RE. Genetics of aging. Science 1997; 278:407–411.
Finch CE. Longevity, senescence and the genome. Chicago: University of Chicago Press, 1990.
Rothstein G. White cell disorders. In: Hazzard WR, Bierman EL, Blass JP, et al. (eds.): Principles of Geriatric Medicine, 3rd Ed. New York: McGraw-Hill, 1994, pp. 749–762.
If such a reference is necessary, include the name, title, month, and year as well as a letter granting permission to publish from the person providing the information. Personal communication references should be included in the reference list in order of citation.
The author must obtain permission to reproduce figures, tables, or text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned and should be supplied to the Editor-in-Chief of Rejuvenation Research. An appropriate acknowledgement should be included to reflect the permission and full publication information cited in the references. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the submitted manuscript.
Unless rejected for publication, all submissions become the property of Mary Ann Liebert, Inc.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Rejuvenation Research is owned and published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.